ロード中...

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

PURPOSE: Fluorouracil/leucovorin as the sole therapy for metastatic colorectal cancer (CRC) provides an overall survival of 8 to 12 months. With an increase in surgical resections of metastatic disease and development of new chemotherapies, indirect evidence suggests that outcomes for patients are i...

詳細記述

保存先:
書誌詳細
主要な著者: Kopetz, Scott, Chang, George J., Overman, Michael J., Eng, Cathy, Sargent, Daniel J., Larson, David W., Grothey, Axel, Vauthey, Jean-Nicolas, Nagorney, David M., McWilliams, Robert R.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2720081/
https://ncbi.nlm.nih.gov/pubmed/19470929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.5278
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!